TD Cowen raised the firm’s price target on Iqvia to $270 from $239 and keeps an Outperform rating on the shares. The firm thinks underlying fundamentals are improving in TAS as the pipeline is at a record high and discretionary businesses saw some sequential improvement in 4Q23. Cowen believes guidance leaves room for outperformance in 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IQV: